Aptevo Therapeutics Inc Earning Date (APVO)

USA |NASDAQ |USD

APVO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 12, 2022 (est) Jun 30, 2022 - $-1.55 $-1.75
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 12, 2022 (est) Jun 30, 2022 - $3.11M $3.11M

Aptevo Therapeutics Inc's next estimated earnings date (based on same quarter last year's date) is Aug 12, 2022 for the fiscal quarter ending Jun 30, 2022.

APVO Earnings Date & History Chart

APVO Earnings & Revenue Forecast

APVO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $-4.23 $-4.23 $-4.23

APVO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $-5.18 $-5.18 $-4.84

APVO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $15.90M $13.80M $18.00M

APVO Earnings Date & Revenue History

APVO Earnings History

|
Show More
Show More

APVO Revenue History

|
Show More
Show More

Aptevo Therapeutics Inc Next Earnings Date & Report

APVO May 2022 (FQ) Earnings Date & Report Preview

APVO's next estimated earnings date (based on same quarter last year's report date) is Aug 12, 2022 for the fiscal quarter ending Jun 30, 2022.

Aptevo Therapeutics Inc Previous Earnings Dates & Reports

APVO Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Aptevo Therapeutics Inc's previous earnings date was May 12, 2022 for its fiscal quarter ended Mar 31, 2022.

APVO's earnings per share (EPS) was $-1.55, missing the consensus analysts forecast of $-1.15 by -34.78%.

The EPS was lower than the previous fiscal quarter (Dec 2021) by 22.05%, and higher than the same period a year before (Mar 2021) by -5.49%.

Revenues were $3.11M.

The company reported a net income of $-7.70M.

Free cash flow for the quarter was $-5.12M , compared to $-4.00M last quarter and $-7.70M a year before.

APVO ended the quarter with $5.87M in total debt, a decrease of -54.88% compared to the previous quarter, and a decrease of -65.27% compared to the same quarter a year before.

APVO Previous Earnings Date & Report Recap: Dec 2021 (FY)

Aptevo Therapeutics Inc's previous annual earnings date was Mar 24, 2022 for its fiscal year ended Dec 31, 2021.

APVO's earnings per share (EPS) was $-6.09, missing the consensus analysts forecast of $-5.81 by 4.82% , and lower than the previous year's EPS (Dec 2020) by 16.44%.

Revenues were $12.29M, better than the forecast of $12.01M by 2.35%, and up by 185.26% from previous year's revenue.

The company reported a net income of $-28.46M.

Aptevo Therapeutics Inc reported a free cash flow of $-22.39M for its fiscal year, compared to $-29.41M a year ago.

The company ended the fiscal year with $13.01M in total debt, an increase of 30.08% compared to the previous year.